Quantitative evaluation of leukocyte and immunoglobulin production in women undergoing treatment for depression
DOI:
https://doi.org/10.33448/rsd-v9i9.7614Keywords:
Leukocytes; Antibody-producing cells; Depression; Mental health.Abstract
Objective: to verify possible changes in immune system cells (leukogram) and immunoglobulins in women with depression. Methodology: this is an observational, cross-sectional and analytical study conducted with 50 women (with depression n=25; no depression n=25) living in the Araguaia Valley region, Brazil. The women were investigated by collecting a peripheral blood sample, and the concentrations of leukocytes were determined by counting cells by flow cytometry and immunoglobulin concentrations by immunoturbidimetry. The data obtained were analyzed by the Kruskal-Wallis and DUNN tests. This study was approved by an Ethics and Research Committee (CAAE: 34568014.8.0000.5587). Results: the sample consisted of women with a mean age of 37±10,59 years, white/brown and single. Non-smoking women who did not have a habit of consuming alcoholic beverages prevailed. Depression was present among 50% of the sample. Regarding the evaluation of leukogram between the groups (with depression and without depression), a significant difference was observed in the serum value of basophils and the total concentrations of Immunoglobulins did not present significant differences between the groups. Conclusion: in this study, depression did not interfere in the concentration of leukocytic cells or in the production of immunoglobulins, and may be related to the long-term use of psychiatric drugs, because they have immunomodulatory properties, highlighting the importance of performing a treatment and follow-up for Depression.
References
Abbas, A. K., Lichtman, A. H., & Pillai, S. (2012). Imunologia Celular e Molecular, 7ª Edição. Editora Elsevier.
Al-Hakeim H. K. (2008). Serum cortisol, immunoglobulins and some complements among depressed patients. Indian journal of clinical biochemistry: IJCB, 23(1), 76–80. doi:10.1007/s12291-008-0018-2
Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., … Maes, M. (2013). So depression is an inflammatory disease, but where does the inflammation come from? BMC Medicine, 11(1). doi:10.1186/1741-7015-11-200
Chica, A., González-Guirval, F., Reigal, R.E., Carranque, G., & Hernández-Mendo, A. (2019). Efectos de un programa de danza española en mujeres con fibromialgia. Cuadernos de Psicología Del Deporte, 19(2), 52–69. doi:10.6018/cpd.343401
Cunha, J. A. (2001). Manual da versão em português das Escalas Beck. São Paulo: casa do psicólogo, 256.
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience, 9(1), 46–56. doi:10.1038/nrn2297
Euteneuer, F., Schwarz, M. J., Dannehl, K., Hartung, A., Westermann, S., & Rief, W. (2012). Increased soluble interleukin-2 receptor levels are related to somatic but not to cognitive-affective features in major depression. Brain, Behavior, and Immunity, 26(8), 1244–1248. doi:10.1016/j.bbi.2012.06.007
Gold, P. W., Pavlatou, M. G., Carlson, P. J., Luckenbaugh, D. A., Costello, R., Bonne, O., Kling, M. A. (2012). Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A. Neuroscience Letters, 520(1), 1–5. doi:10.1016/j.neulet.2012.04.072
Gomes, A., Ramos, S., Ferreira, A. R., Montalvão, J., Ribeiro, I., & Lima, F. (2019). A efetividade do exercício físico no tratamento da depressão. Revista Portuguesa de Enfermagem de Saúde Mental, (22), 58-64. doi: 10.19131/rpesm.0264
Grosse, L., Carvalho, L. A., Wijkhuijs, A. J. M., Bellingrath, S., Ruland, T., Ambrée, O., Arolt, V. (2015). Clinical characteristics of inflammation-associated depression: Monocyte gene expression is age-related in major depressive disorder. Brain, Behavior, and Immunity, 44, 48–56. doi:10.1016/j.bbi.2014.08.004
Hestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003). Raised Plasma Levels of Tumor Necrosis Factor α in Patients With Depression. The Journal of ECT, 19(4), 183–188. doi: 10.1097/00124509-200312000-00002
Himmerich, H., Milenović, S., Fulda, S., Plümäkers, B., Sheldrick, A. J., Michel, T. M., Rink, L. (2010). Regulatory T cells increased while IL-1β decreased during antidepressant therapy. Journal of Psychiatric Research, 44(15), 1052–1057. doi: 10.1016/j.jpsychires.2010.03.005
Irwin, M., Patterson, T., Smith, T. L., Caldwell, C., Brown, S. A., Gillin, J. C., & Grant, I. (1990). Reduction of immune function in life stress and depression. Biological Psychiatry, 27(1), 22–30. doi: 10.1016/0006-3223(90)90016-u
Janssen, D. G. A., Caniato, R. N., Verster, J. C., & Baune, B. T. (2010). A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Human Psychopharmacology: Clinical and Experimental, 25(3), 201–215. doi:10.1002/hup.1103
Jaremka, L. M., Lindgren, M. E., & Kiecolt-Glaser, J. K. (2013). Synergistic Relationships Among Stress, Depression, and Troubled Relationships: Insights from Psychoneuroimmunology. Depression and Anxiety, 30(4), 288–296. doi:10.1002/da.22078
Kiecolt-Glaser, J. K., & Glaser, R. (2002). Depression and immune function. Journal of Psychosomatic Research, 53(4), 873–876. doi:10.1016/s0022-3999(02)00309-4
Koo, J. W., & Duman, R. S. (2008). IL-1 is an essential mediator of the antineurogenic and anhedonic effects of stress. Proceedings of the National Academy of Sciences, 105(2), 751–756. doi:10.1073/pnas.0708092105
Krishnadas, R., & Cavanagh, J. (2012). Depression: an inflammatory illness? Journal of Neurology, Neurosurgery & Psychiatry, 83(5), 495–502. doi:10.1136/jnnp-2011-301779
Kronfol, Z., & House, J. D. (1989). Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiatrica Scandinavica, 80(2), 142–147. doi:10.1111/j.1600-0447.1989.tb01316.x
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011). In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(3), 744–759. doi:10.1016/j.pnpbp.2010.08.026
Lanquillon, S., Krieg, J. C., Bening-Abu-Shach, U., & Vedder, H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22(4), 370-379. doi: 10.1016/S0893-133X(99)00134-7
Lemes, A. G., Nascimento, V. F., Rocha, E. M., Almeida, M. A. S. O., Volpato, R. J., & Luis, M. A. V. (2020b). Terapia Comunitária como cuidado complementar a usuários de drogas e suas contribuições sobre a ansiedade e a depressão. Escola Anna Nery, 24(3), e20190321. doi:10.1590/2177-9465-ean-2019-0321
Lemes, A. G., Rocha, E. M. D., Nascimento, V. F. D., Volpato, R. J., Almeida, M. A. S. O., Franco, S. E. D. J., ... Luis, M. A. V. (2020a). Beneficios de la terapia comunitaria integrativa revelados por usuarios de sustancias psicoactivas. Acta Paulista de Enfermagem, 3, e-APE20190122. doi: 10.37689/acta-ape/2020ao0122
Leonard, B., & Maes, M. (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neuroscience & Biobehavioral Reviews, 36(2), 764–785. doi:10.1016/j.neubiorev.2011.12.005
Lieb, J. (2002). Lithium and antidepressants: inhibiting eicosanoids, stimulating immunity, and defeating microorganisms. Medical Hypotheses, 59(4), 429–432. doi:10.1016/s0306-9877(02)00148-2
Lieb, J. (2007). Lithium and antidepressants: Stimulating immune function and preventing and reversing infection. Medical Hypotheses, 69(1), 8–11. doi:10.1016/j.mehy.2006.12.005
Lima, I. V. M., Sougey, E. B., Vallada Filho, H. P. (2004). Farmacogenética do tratamento da depressão: busca de marcadores moleculares de boa resposta aos antidepressivos. Archives of Clinical Psychiatry, 31(1), 40-43. doi:10.1590/S0101-60832004000100007
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010). Overweight, Obesity, and Depression. Archives of General Psychiatry, 67(3), 220. doi:10.1001/archgenpsychiatry.2010.2
Maes, M., Van Der Planken, M., Stevens, W. J., Peeters, D., DeClerck, L. S., Bridts, C. H., Cosyns, P. (1992). Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression. Journal of Psychiatric Research, 26(2), 125–134. doi:10.1016/0022-3956(92)90004-8
Miller, A. H. (2010). Depression and immunity: a role for T cells? Brain, behavior, and immunity, 24(1), 1–8. https://doi.org/10.1016/j.bbi.2009.09.009
Nóbrega, W. F.S., Oliveira, M. E. C., Gomes, K. A. L., Palmeira, J. T., Barbosa, D. V., Silva, G. C. B. (2020). Depressão na vida acadêmica: quais fatores estão associados? Research, Society and Development, 9(8), e256985719, 2020. doi:10.33448/rsd-v9i8.5719
Olympio, P. C. A. P. (2008). Níveis de imunoglobulina A salivar, ansiedade, estresse e depressão de mulheres mastectomizadas em uso de tamoxifeno [Dissertação de Mestrado]. Universidade Federal do Espírito Santo, Vitória, Espirito Santo, Brasil. Recuperado de http://www.dominiopublico.gov.br/pesquisa/DetalheObraForm.do?select_action=&co_obra=165647
Pae, C.-U., Sohi, M. S., Seo, H.-J., Serretti, A., Patkar, A. A., Steffens, D. C., & Masand, P. S. (2010). Quetiapine XR: Current status for the treatment of major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(7), 1165–1173. doi:10.1016/j.pnpbp.2010.03.023
Pasco, J. A., Nicholson, G. C., Williams, L. J., Jacka, F. N., Henry, M. J., Kotowicz, M. A., Berk, M. (2010). Association of high-sensitivity C-reactive protein with de novo major depression. British Journal of Psychiatry, 197(05), 372–377. doi:10.1192/bjp.bp.109.076430
Postal, M., & Appenzeller, S. (2015). The importance of cytokines and autoantibodies in depression. Autoimmunity Reviews, 14(1), 30–35. doi:10.1016/j.autrev.2014.09.001
Reiche, E. M. V., Nunes, S. O. B., Morimoto, H. K. (2005). Disfunções no sistema imune induzidas pelo estresse e depressão. Revista Brasileira de Oncologia Clínica, 1(5), 19-28. Recuperado de https://www.researchgate.net/publication/273258908_Disfuncoes_no_Sistema_Imune_Induzidas_pelo_Estresse_e_Depressao_Implicacoes_no_Desenvolvimento_e_Progressao_do_Cancer
Ribeiro, W. A., Marchi, M. V., Marins, S. A., Gonçalves, T. A. S. (2020). Fatores de risco para a depressão no cotidiano da equipe de Enfermagem no âmbito hospitalar. Research, Society and Development, 9(8), e16985287. doi:10.33448/rsd-v9i8.5287
Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011). Functional Biomarkers of Depression: Diagnosis, Treatment and Pathophysiology. Neuropsychopharmacology, 36(12), 2375-2394. doi:10.1038/npp.2011.151
Silva, L. S., Almeida, M. A. S. O., da Rocha, E. M., Volpato, R. J., de Oliveira, P. R., do Nascimento, V. F., & Lemes, A. G. (2019). Depressão entre acadêmicos de enfermagem e os fatores sociodemográficos associados. Revista Eletrônica Acervo Saúde, 11(17), e1524-e1524. doi: 10.25248/reas.e1524.2019
Sluzewska, A., Sobieska, M., & Rybakowski, J. K. (1997). Changes in Acute-Phase Proteins during Lithium Potentiation of Antidepressants in Refractory Depression. Neuropsychobiology, 35(3), 123–127. doi:10.1159/000119332
Smith, R. S. (1991). The macrophage theory of depression. Medical Hypotheses, 35(4), 298-306. doi:10.1016/0306-9877(91)90272-z
Stahl, S. M. (1998). Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. Journal of Clinical Psychiatry, 59 (Suppl 4), 5-14. Recuperado de https://pubmed.ncbi.nlm.nih.gov/9554316/
Toben, C., & Baune, B. T. (2015). An Act of Balance Between Adaptive and Maladaptive Immunity in Depression: a Role for T Lymphocytes. Journal of Neuroimmune Pharmacology, 10(4), 595–609. doi:10.1007/s11481-015-9620-2
Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., Martín-Santos, R. (2012). Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. The Journal of clinical psychiatry, 73(8), 1128-1138. doi:10.4088/JCP.12r07694
Vismari, L., Alves, G. J., & Palermo-Neto, J. (2008). Depressão, antidepressivos e sistema imune: um novo olhar sobre um velho problema. Archives of Clinical Psychiatry, 35(5), 196-204. doi: 10.1590/S0101-60832008000500004
Vogelzangs, N., Duivis, H. E., Beekman, A. T., Kluft, C., Neuteboom, J., Hoogendijk, W., Penninx, B. W. (2012). Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Translational psychiatry, 2(2), e79-e79. doi:10.1038/tp.2012.8
Walker, F. R. (2013). A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology, 67, 304-317. doi: 10.1016/j.neuropharm.2012.10.002
World Health Organization. (2012). Fact sheet: Obesity and overweight. Recuperado de https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., Schmidt, K. (2001). The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain, behavior, and immunity, 15(3), 199-226. doi:10.1006/brbi.2000.0597
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Alisséia Guimarães Lemes; Rosa Jacinto Volpato; Adaene Alves Machado de Moura ; Tatiele Estefâni Schönholzer; Vagner Ferreira do Nascimento; Paula Cristina de Souza Souto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
